These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36907709)

  • 21. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
    Ueda M; Kusunoki S
    Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis.
    Yan W; Nguyen T; Yuki N; Ji Q; Yiannikas C; Pollard JD; Mathey EK
    J Neuroimmunol; 2014 Dec; 277(1-2):13-7. PubMed ID: 25262157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HIV-associated neuropathies].
    Hahn K; Husstedt IW;
    Nervenarzt; 2010 Apr; 81(4):409-17. PubMed ID: 20195565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.
    Latov N
    Nat Rev Neurol; 2014 Aug; 10(8):435-46. PubMed ID: 24980070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
    Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
    Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
    Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
    Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
    Franssen H; Straver DC
    Muscle Nerve; 2014 Jan; 49(1):4-20. PubMed ID: 24037667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dysimmune neuropathies: current diagnosis and therapy].
    Léger JM; Larue S; Dashi F
    Rev Prat; 2008 Nov; 58(17):1887-9, 1892-4. PubMed ID: 19157204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
    van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
    Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune-mediated neuropathies: pathophysiology and management].
    Tian YY; Yuan PP; Wang XG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Sep; 58(9):1432-1437. PubMed ID: 39290027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of inflammatory and paraproteinemic neuropathies.
    Monaco S; Turri E; Zanusso G; Maistrello B
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):141-8. PubMed ID: 15180454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in inflammatory neuropathies: the IN-QoL.
    Draak THP; Faber CG; Merkies ISJ;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune polyneuropathies.
    Naum R; Gwathmey KG
    Handb Clin Neurol; 2023; 195():587-608. PubMed ID: 37562888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis, epidemiology and treatment of inflammatory neuropathies.
    Baig F; Knopp M; Rajabally YA
    Br J Hosp Med (Lond); 2012 Jul; 73(7):380-5. PubMed ID: 22875431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
    Doppler K; Appeltshauser L; Villmann C; Martin C; Peles E; Krämer HH; Haarmann A; Buttmann M; Sommer C
    Brain; 2016 Oct; 139(Pt 10):2617-2630. PubMed ID: 27474220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.